期刊文献+

他汀类药物对神经细胞和神经胶质细胞ABCA1基因表达的影响 被引量:3

Effect of statins on ABCA1 gene expression in neurons and astrocytes
下载PDF
导出
摘要 目的观察他汀类药物对神经细胞和神经胶质细胞ATP结合盒式转运体1(ATP-binding cassette transporter1,ABCA1)基因表达的影响。方法培养人类神经细胞和神经胶质细胞,分别加入不同浓度的辛伐他汀(si mvastatin)和普伐他汀(pravastatin),孵育不同时间后分别提取细胞总RNA和胞质蛋白,RT-PCR观察ABCA1基因的表达,Western blot检测ABCA1蛋白。结果辛伐他汀和普伐他汀组显著降低了ABCA1基因和蛋白的表达,其中辛伐他汀的作用比普伐他汀明显(辛伐他汀对神经元和神经胶质细胞ABCA1基因表达分别降低95%和75%P<0.05),神经元实验组比神经胶质细胞组更为敏感。结论他汀类药物可以显著降低神经元和神经胶质细胞ABCA1基因和蛋白的表达,ABCA1的降低有可能影响细胞内胆固醇的代谢,对全面评价他汀类药物对高血脂相关基因的影响及用药安全性提供了一定的实验依据。 Objective To observe the effects of statins on ATP-binding cassette transporter 1(ABCA1) gene expression in neurons and astrocytes.Methods Primary human astrocytes and neuron cell line HCN-2 were incubated with simvastatin and pravastatin at different concentrations and under different conditions.Using RNA isolated from the cultured cells,we performed quantitative PCR to measure the ABCA1 gene expression in astrocytes and neurons.The protein expression of ABCA1 was measured by Western blot.Results The two statins significantly decreased the ABCA1 gene and protein expressions.Compared with pravastatin,simvastatin significantly reduced the expression of ABCA1 in neurons and astrocytes by 95% and 75%,respectively(both P0.05).The neurons were more sensitive than astrocytes.Conclusion The statins are capable of decreasing the ABCA1 gene and protein expressions in neurons and astrocytes,and decreased ABCA1 expression may affect cholesterol metabolism in cells.The results may provide an important experimental basis for comprehensive evaluation of the statins to treat hyperlipidemia.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期527-530,565,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 美国NIH NHLBI资助项目(HL03006) 国家自然科学基金资助项目(No.30400515) 陕西省科技攻关项目(No.2005K13-G2)~~
关键词 ATP结合盒式转运体1 辛伐他汀 普伐他汀 ATP-binding cassette transporter 1(ABCA1) simvastatin pravastatin
  • 相关文献

参考文献14

  • 1WERNER N,NICKENIG G,LAUFS U.Pleiotropic effects of HMG-CoA reducatese inhibitors[J].Basic Res Cardiol,2002,97(2):106-116.
  • 2MIIDA T,HIRAYAMA S,NAKAMURA Y.Cholesterol-independent effects of statins and new therapeutic targets:ischemic stroke and dementia[J].J Atheroscler Thromb,2004,11 (5):253-264.
  • 3AUER J,BERENT R,EBER B.Lessons learned from statin trials[J].Clin Cardiol,2001,24(4):277-280.
  • 4BROUSSEAU ME,EBERHART GP,DUPUIS J,et al.Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high-density lipoprotein cholesterol concentration and particle size[J].J Lipid Res,2000,41(7):1125-1135.
  • 5SCHAEFER JR,SCHWEER H,IKEWAKI K.Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease[J].Atherosclerosis,1999,144(1):177 184.
  • 6KURINAMI H,SATO N,SHINOHARA M,et al.Prevention of amyloid beta-induced memory impairment by fluvastatin,associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model[J].Int J Mol Med,2008,21(5):531-537.
  • 7ORSI A,SHERMAN O,WOLDESEKASSIE Z.Simvastatin-associated memory loss[J].Pharmacotherapy,2001,21(6):767-769.
  • 8KING DS,WlLBURN AJ,WOFFORD MR,et al.Cognitive impairment associated with atorvastatin and simvastatin[J].Pharmacotherapy,2003,23(12):1663-1667.
  • 9WAGSTAFF LR,MITTON MW,ARVIK BM,et al.Statin-associated memory loss:analysis of 60 case reports and review of the literature[J].Pharmacotherapy,2003,23(7):871-880.
  • 10PHILLIPS MC,GILLOTTE KL,HAYNES MP.Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes[J].Atherosclerosis,1998,137(soppl):13-17.

同被引文献27

  • 1鲁效慧.他汀类药物在临床用药中的合理性和安全性[J].今日健康,2016,15(12):60-60. 被引量:1
  • 2Furnari FB,Fenton T,Bachoo RM,et al.Malignant astrocyticglioma:genetics,biology,and paths to treatment[J].GenesDev,2007,21(21):2683-2710.
  • 3Jung CG,Horike H,Cha BY,et al.Honokiol increases ABCA1expression level by activating retinoid X receptor beta[J].BiolPharm Bull,2010,33(7):1105-1111.
  • 4Guo D,Reinitz F,Yousef M,et al.An LXR agonist promotesglioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR--dependent pathway[J].Cancer Discov,2011,1(5):442-456.
  • 5Surh YJ,Kundu JK,Li MH,et al.Role of Nrf2-mediated hemeoxygenase-1 upregulation in adaptive survival response to ni-trosative stress[J].Arch Pharm Res,2009,32(8):1163-1176.
  • 6Louis DN,Ohgaki H,Wiestler OD,et al.The 2007 WHO classi-fication of tumours of the central nervous system[J].Acta Neu-ropathol,2007,114(2):97-109.
  • 7Wong ML,Kaye AH,Hovens CM.Targeting malignant gliomasurvival signalling to improve clinical outcomes[J].J Clin Neu-rosci,2007,14(4):301-308.
  • 8Santamarina-Fojo S,Remaley AT,Neufeld EB,et al.Regulationand intracellular trafficking of the ABCA1 transporter[J].J LipidRes,2001,42(9):1339-1345.
  • 9Iatan I,Bailey D,Ruel I,et al.Membrane microdomains modu-late oligomeric ABCA1 function:impact on apoAI-mediated lipidremoval and phosphatidylcholine biosynthesis[J].J Lipid Res,2011,52(11):2043-2055.
  • 10Fukumoto H,Deng A,Irizarry MC,et al.Induction of thecholesterol transporter ABCA1 in central nervous system cells byliver X receptor agonists increases secreted Abeta levels[J].JBiol Chem,2002,277(50):48508-48513.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部